BioSpace News Archive

Biopharma and life sciences companies provide updates on their pipelines and business plans.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 3, 2020.

It’s a relatively slow month ahead for July in terms of PDUFA dates for the U.S. FDA. However, there are several dates pending throughout the month. Here’s a look at three for the next two weeks.

Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.

Milestone Scientific Inc. today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.5

XCART technology platform is a significantly differentiated, proprietary approach to personalized CAR T therapy for the treatment of multiple tumor types of B-cell Non-Hodgkin lymphoma (NHL)

Rexgenero announces that Dr Gilbert Wagener has joined the Company as Senior Vice President and Chief Medical Officer.

$250,000 grant to establish virtual training for lab and data analytics awarded by Bill & Melinda Gates Foundation

AdaptHealth Corp. announced that it has closed the previously announced acquisitions of Solara Medical Supplies, LLC and ActivStyle, Inc.

Continuous, Active Air Purifier Uses NASA-inspired ActivePure Technology DALLAS, TX / ACCESSWIRE / June 30, 2020 / Aerus, committed to providing cutting-edge technologies to create the healthiest indoor environments around the world, announced today that it received Class II Medical Device clearance from the U.S. Food and Drug Administration (FDA) for the Aerus Medical Guardian with ActivePure Technology, the first active air purifier for health care. ActivePure is the most powerful surf